Search
Search
During process development and early manufacturing, purification challenges often emerge after standard chromatography resins have been evaluated. Aggregate removal may be limited. Host cell protein (HCP) clearance may be insufficient despite optimization in buffer conditions. In some processes, pressure constraints can limit target residence times, which can impact productivity.
When standard chromatography resins no longer respond to further changes in operating conditions and material properties become the limiting factor, POROS chromatography resins should be evaluated. In these cases, bead architecture and flow behavior define whether the required separation performance can be achieved within the available operating window.
Custom development often raises concerns around timelines, scope creep, and how many iterations it will take to reach a usable outcome. For POROS resins, development follows a defined, milestone-based path, with screening and decision points tied to process-relevant data. This structure helps maintain alignment with the customer’s purification objectives while allowing adjustments when the data warrants them.
Transitioning from development to manufacturing can expose gaps that were not apparent at a small scale, particularly around flow performance, robustness, and reproducibility. Thermo Fisher Scientific custom POROS resin development accounts for these constraints early, with design choices evaluated for how they translate across scale-up and defined operating ranges.
A custom POROS resin is typically considered when continued optimization or screening of standard chromatography resins no longer produces meaningful improvements. This often occurs when limits in selectivity, aggregate removal, impurity clearance, or flow performance persist despite process adjustments. At that point, further operating changes tend to confirm the same limitations.
Development can begin before the process is fully defined. Early work often starts with what is already known about the molecule and feedstream, even if operating ranges or step sequencing are still changing. As prototype data is generated, those assumptions are tested and refined, allowing process definition to progress alongside resin development.
Development risk is managed by intentionally limiting scope at each stage. Screening focuses on a small, defined set of variables directly tied to the observed process constraint, with clear decision points before advancing. Data from each phase is reviewed before expanding scope, so designs that do not shift performance positively are stopped early.
Performance is evaluated using prototype resins tested under conditions that reflect the intended process. This includes defined residence times, load challenges, and the use of representative feedstreams. Data is reviewed against the original performance constraint, such as resolution, impurity clearance, or flow behavior, before a decision is made to advance toward larger-scale implementation.
Scale-up is considered while the resin is still being designed, not after performance has been demonstrated at a small scale. Bead structure, surface chemistry, and pressure–flow behavior are evaluated with an eye toward how they translate across column diameters and operating ranges. This helps reduce changes later when adjustments become harder to accommodate during manufacturing.
For Research Use Only. Not for use in diagnostic procedures.